Mesoblast (MESO) Free Cash Flow (2016 - 2023)

Mesoblast (MESO) has reported Free Cash Flow for 8 consecutive years, with -$16.5 million the latest figure, recorded in Q2 2023.

• Quarterly Free Cash Flow fell 18.7% year-over-year to -$16.5 million in Q2 2023, while the trailing twelve-month figure through Dec 2024 was -$16.5 million (up 66.48% YoY) and the FY2025 annual result came in at -$50.7 million, down 4.0% from the prior year.
• Free Cash Flow eased to -$16.5 million in Q2 2023 per MESO's latest filing, from -$16.2 million in the prior quarter.
• Over the last five years, Free Cash Flow for MESO reached as high as -$1.3 million in Q4 2019 and fell as low as -$30.6 million in Q4 2020.
• A 5-year average of -$17.9 million and a median of -$17.3 million in 2021 frame the typical range for Free Cash Flow.
• Annual changes were most pronounced in 2020 — Free Cash Flow plunged 2199.25% — and 2021, when it jumped 40.42%.
• Year by year, Free Cash Flow stood at -$1.3 million in 2019, then tumbled by 2199.25% to -$30.6 million in 2020, then surged by 40.42% to -$18.2 million in 2021, then rose by 9.69% to -$16.5 million in 2022, then declined by 0.23% to -$16.5 million in 2023.
• According to Business Quant data, Free Cash Flow over the past three periods registered -$16.5 million, -$16.2 million, and -$16.5 million for Q2 2023, Q1 2023, and Q4 2022 respectively.